Cost-effectiveness of different treat-to-target strategies in rheumatoid arthritis: results from the DREAM registry by Celine J. van de Laar, Martijn A. H. Oude Voshaar, Harald E. Vonkeman

Get full text

Model-based cost-effectiveness analyses comparing combinations of urate lowering therapy and anti-inflammatory treatment in gout patients. by Celine Johanna van de Laar, Carly A Janssen, Matthijs Janssen, Martijn A H Oude Voshaar, Maiwenn J Al, Mart A F J van de Laar

Get full text

A systematic literature review of patient-reported outcome measures used in gout: an evaluation of their content and measurement properties by Carly A. Janssen, Martijn A. H. Oude Voshaar, Peter M. ten Klooster, Tim L. Th. A. Jansen, Harald E. Vonkeman, Mart A. F. J. van de Laar

Get full text

Radiographic progression can still occur in individual patients with low or moderate disease activity in the current treat-to-target paradigm: real-world data from the Dutch Rheuma... by Peter M. ten Klooster, Letty G. A. Versteeg, Martijn A. H. Oude Voshaar, Inmaculada de la Torre, Francesco De Leonardis, Walid Fakhouri, Liliana Zaremba-Pechmann, Mart van de Laar

Get full text

Calibration of the PROMIS physical function item bank in Dutch patients with rheumatoid arthritis. by Martijn A H Oude Voshaar, Peter M ten Klooster, Cees A W Glas, Harald E Vonkeman, Erik Taal, Eswar Krishnan, Hein J Bernelot Moens, Maarten Boers, Caroline B Terwee, Piet L C M van Riel, Mart A F J van de Laar

Get full text